title: [Fatty acids in treatment and prevention of depression].
abstract: The increase of incident rates for depression and other psychiatric disorders is a serious threat for all communities. The study presents data verifying the relationship between the level of omega-3 PUFAs in the blood and an increased risk of depression, including the parallel standard therapy with antidepressants or not. There is an increasing number of evidences that fatty acids like DHA, AA and EPA are linked to depression. In epidemiological studies and clinical trials a correlation between the decline of omega-3 PUFA intake and an increasing risk for developing depression is considered.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Wilczyńska
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy* / Q000517:prevention & control; D061218:Depressive Disorder, Treatment-Resistant / Q000188:drug therapy; D004032:Diet; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D009747:Nutritional Physiological Phenomena; D055502:Secondary Prevention
chemical_list: D000928:Antidepressive Agents; D015525:Fatty Acids, Omega-3